0001638599-19-000791.txt : 20190820
0001638599-19-000791.hdr.sgml : 20190820
20190820172040
ACCESSION NUMBER: 0001638599-19-000791
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190816
FILED AS OF DATE: 20190820
DATE AS OF CHANGE: 20190820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clasby Jennifer G
CENTRAL INDEX KEY: 0001728919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 191040571
MAIL ADDRESS:
STREET 1: 501 FIFTH AVENUE
STREET 2: SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
4
1
doc4_6254.xml
PRIMARY DOCUMENT
X0306
4
2019-08-16
0
0001682639
EYENOVIA, INC.
EYEN
0001728919
Clasby Jennifer G
C/O EYENOVIA, INC.
295 MADISON AVENUE, SUITE 2400
NEW YORK
NY
10017
0
1
0
0
VP, Clinical Operations
Common Stock
28965
D
Stock Option (right to buy)
3.11
2019-08-16
4
A
0
42722
0
A
2029-08-16
Common Stock
42722
42722
D
Stock Option (right to buy)
1.95
2027-07-07
Common Stock
51247
51247
D
Stock Option (right to buy)
6.20
2028-07-24
Common Stock
19874
19874
D
One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
The option became exercisable as to 2,228 shares on August 7, 2017 and becomes exercisable in equal 2,228 share amounts on each of the 35 one-month anniversaries thereafter.
One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
/s/ S. Halle Vakani, Attorney-in-Fact
2019-08-20
EX-24
2
exhibit24.htm
EXHIBIT 24
Exhibit 24